This is a standard initial ownership filing with no trading activity. Monitor future Form 4 filings for any insider transactions by Valentine that could signal conviction or changes in outlook.
Price Chart
Executive Summary
James Elwood Valentine filed an initial Statement of Beneficial Ownership (Form 3) with the SEC, reporting his status as a beneficial owner of more than 10% of IRulya Therapeutics Inc. common stock. The filing is a routine administrative requirement triggered by his crossing the 10% ownership threshold and does not disclose any transaction or change in business operations.
Key Facts
- Form 3 filed by James Elwood Valentine on October 19, 2026, with a period of report of October 8, 2026.
- Valentine is a beneficial owner of more than 10% of IRulya Therapeutics Inc. common stock.
- The filing includes a Power of Attorney authorizing Brigette Roberts and John Militello to execute future Section 16 filings on his behalf.
- No securities transactions or changes in ownership are reported in this filing.
Financial Impact
No financial impact; the filing is a routine beneficial ownership disclosure with no monetary value or transaction.
Risk Factors
- No material risks identified from this administrative filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0002159117-26-000002 |
| Document: 0002159117-26-000002-index-headers.html | 0002159117-26-000002 |
| Document: 0002159117-26-000002-index.html | 0002159117-26-000002 |
| Document: 0002159117-26-000002.txt | 0002159117-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 144 | $32.83 | awaiting T+20 | — | $32.47 (−1.08%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 3 | $40.27 | awaiting T+20 | — | $32.47 (−19.36%) |
Oct 19, 2026 8d ago | 8-K | $34.45 | awaiting T+20 | — | $32.47 (−5.73%) |
Oct 14, 2026 13d ago | SC 13G | $33.23 | awaiting T+20 | — | $32.47 (−2.27%) |
Oct 14, 2026 13d ago | SC 13G | $33.23 | awaiting T+20 | — | $32.47 (−2.27%) |
Oct 6, 2026 21d ago | 8-K | $26.72 | awaiting T+20 | — | $32.47 (+21.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers